Erlinger TP, Brancati FL: Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes. Diabetes Care 24:1734–1738, 2001
In the legend for Fig. 1 on page 1737 of the above article, the bars were labeled incorrectly. The black bars represent diabetic patients who are not taking oral agents, and the gray bars represent diabetic patients who are taking oral agents. The figure and the corrected legend are given here.
![Figure 1—. Percentage of adults with diabetes with elevated fasting (A) and 2-h (B) plasma glucose. Columns represent the percentage of U.S. adults aged 40–74 years with diagnosed diabetes not using insulin with fasting (A) hyperglycemia (defined as FPG ≥126 mg/dl) and postprandial (B) hyperglycemia (defined as 2-h plasma glucose ≥200 mg/dl) by level of HbA1c. ▪, Diabetic patients not taking oral agents; [cjs2108], diabetic patients taking oral agents. P < 0.001 for difference at HbA1c <7.0%. Error bars indicate SEM.](/view-large/figure/4173099/dc012erra001.jpeg)
Percentage of adults with diabetes with elevated fasting (A) and 2-h (B) plasma glucose. Columns represent the percentage of U.S. adults aged 40–74 years with diagnosed diabetes not using insulin with fasting (A) hyperglycemia (defined as FPG ≥126 mg/dl) and postprandial (B) hyperglycemia (defined as 2-h plasma glucose ≥200 mg/dl) by level of HbA1c. ▪, Diabetic patients not taking oral agents; [cjs2108], diabetic patients taking oral agents. P < 0.001 for difference at HbA1c <7.0%. Error bars indicate SEM.
Percentage of adults with diabetes with elevated fasting (A) and 2-h (B) plasma glucose. Columns represent the percentage of U.S. adults aged 40–74 years with diagnosed diabetes not using insulin with fasting (A) hyperglycemia (defined as FPG ≥126 mg/dl) and postprandial (B) hyperglycemia (defined as 2-h plasma glucose ≥200 mg/dl) by level of HbA1c. ▪, Diabetic patients not taking oral agents; [cjs2108], diabetic patients taking oral agents. P < 0.001 for difference at HbA1c <7.0%. Error bars indicate SEM.
